ACHE and early-onset autosomal dominant Alzheimer disease: Several series of simple 3-phenylcoumarins have been studied to prevent and treat Alzheimer’s disease and its complications, showing high activity toward AChE and MAO, together with antioxidant activity (Figure 11).